50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today APTO ranks #11792 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Aptose Biosciences Stock Forecast NASDAQ:APTO

$2.28 (-5.00%)

Volume: 714k

Closed: Nov 26, 2021

Hollow Logo Score: -4.247

Aptose Biosciences Stock Forecast

$2.28 (-5.00%)

Volume: 714k

Closed: Nov 26, 2021

Score Hollow Logo -4.247
Which way will APTO go? Request
Key Stats
Beta 1.03
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 43 and the stock is currently not being overbought or oversold

Red day on Friday for Aptose Biosciences stock after losing 5%
(Updated on Nov 26, 2021)


Sell candidate since 2021-11-26

The Aptose Biosciences stock price fell by -5.00% on the last day (Friday, 26th Nov 2021) from $2.40 to $2.28. and has now fallen 3 days in a row. During the day the stock fluctuated 7.14% from a day low at $2.24 to a day high of $2.40. The price has fallen in 6 of the last 10 days and is down by -5% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -81 thousand shares and in total, 714 thousand shares were bought and sold for approximately $1.63 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.14% during the next 3 months and, with a 90% probability hold a price between $1.57 and $2.27 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are few to no technical positive signals at the moment. The Aptose Biosciences stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.45 and $2.33. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 16, 2021, and so far it has fallen -17.39%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

Aptose Biosciences finds support from accumulated volume at $2.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.16 between high and low, or 7.14%. For the last week, the stock has had a daily average volatility of 6.29%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Aptose Biosciences stock A Buy?

Aptose Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.247

Predicted Opening Price for Aptose Biosciences of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$2.31 $2.28 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 12, 2021 "HC Wainwright" gave "$9.00 - $14.00" rating for APTO. The price target was set to $2.40+0.4%.

Volatility and Risk
Daily Average Volatility: 6.29 %
Overall Risk: Very High High Medium Low Very Low
Volatility
6.29 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $2.44
Price: $2.28
Support: $2.18

APTO Insider Trading Show all Trades

INSIDER POWER

10.690

Last 79 transactions
Buy: 9 186 264 | Sell: 859 340 (Shares)
Date Action Amount Person Type
Aug 19, 2021 Buy 200 000 Bejar Rafael Performance Stock Option
Aug 19, 2021 Buy 200 000 Marango Jotin Performance Stock Option
Aug 05, 2021 Sell 60 000 Wilson Donald R. Jr. Common Stock
Aug 03, 2021 Buy 57 199 Wilson Donald R. Jr. Common Stock
Jul 02, 2021 Buy 6 081 Rice William G. Common shares
Show all Insider Trades
INSIDER POWER

10.690

Last 79 transactions
Buy: 9 186 264 | Sell: 859 340 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 2.47 8.19 %
2.41 5.51 %
2.37 3.85 %
Current price: 2.28
Support 2.25 -1.51 %
2.21 -3.17 %
2.15 -5.85 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 2.64 15.79 %
2.48 8.77 %
2.44 7.02 %
Current price 2.28
Support 2.18 -4.39%
2.12 -7.02%
2.09 -8.33%

Click to get the best stock tips daily for free!

About Aptose Biosciences

Aptose Biosciences Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, a small molecule that induces the transcription of the Krüppel-like factor 4 Gene in in vitro studies and in in vivo pharmacodynamic studies of human xenograft tumors in mice. The company’s APTO-253 clinical program has completed Phase-I clinic... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT